Morning Momentum Movers: TZOO, HRVE, MSGI, RSAS, NABI
Up)
Morning Momentum Movers:
Travelzoo Inc. (NASDAQ: TZOO) is 45% higher after the company reported Q1 EPS of $0.24, 10 cents better than estimates. Revenues were $16.9 million vs. $14.71 million consensus.
Harvey Electronics, Inc. (NASDAQ: HRVE) is 41% higher after the company announced today that it would receive approximately $4.0 million in growth capital from several institutional investors led by Trinity Investment Partners LLC
MSGI Security Solutions, Inc. (NASDAQ: MSGI) is 32% higher after the company executed an exclusive $20 million agreement with the security division of a multi-billion dollar firm in a major middle eastern nation for the design and deployment of a city-wide video surveillance solution, in an area with a population exceeding three million residents
RSA Security Inc. (NASDAQ: RSAS) is 10.7% higher after strong Q2 results and guidance. In addition, Brean Murray upgraded the stock.
Nabi Biopharmaceuticals (NASDAQ: NABI) is 7.5% higher after Third Point LLC, run by activist shareholder Daniel Loeb, disclosed an 8.4% stake in Nabi. Loeb urged the company to retain a new investment banking firm to implement a strategic process aimed at maximizing stockholder value.
Travelzoo Inc. (NASDAQ: TZOO) is 45% higher after the company reported Q1 EPS of $0.24, 10 cents better than estimates. Revenues were $16.9 million vs. $14.71 million consensus.
Harvey Electronics, Inc. (NASDAQ: HRVE) is 41% higher after the company announced today that it would receive approximately $4.0 million in growth capital from several institutional investors led by Trinity Investment Partners LLC
MSGI Security Solutions, Inc. (NASDAQ: MSGI) is 32% higher after the company executed an exclusive $20 million agreement with the security division of a multi-billion dollar firm in a major middle eastern nation for the design and deployment of a city-wide video surveillance solution, in an area with a population exceeding three million residents
RSA Security Inc. (NASDAQ: RSAS) is 10.7% higher after strong Q2 results and guidance. In addition, Brean Murray upgraded the stock.
Nabi Biopharmaceuticals (NASDAQ: NABI) is 7.5% higher after Third Point LLC, run by activist shareholder Daniel Loeb, disclosed an 8.4% stake in Nabi. Loeb urged the company to retain a new investment banking firm to implement a strategic process aimed at maximizing stockholder value.
You May Also Be Interested In
- Savient Pharma (SVNT) Moves Higher with Volatility; Bumps Up Against Key Resistance Point
- SodaStream (SODA) Shares Volatile as Exec Says Co. Received Approval to Sell Products in Brazil
- Siliconware Precision (SPIL) Shares Drop on Volatility Spike
Create E-mail Alert Related Categories
Momentum Movers, Special ReportsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
